Royal Bank of Canada
RY
The Toronto-Dominion Bank
TD
Canadian Imperial Bank of Commerce
CM
Bank of Montreal
BMO
Bank of Nova Scotia
BNS
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | -38.91%31.68K | -48.20%56.77K | 5.41%55.32K | 166.38%357.6K | 434.61%143.66K | 27.54%51.86K | 139.30%109.59K | 150.99%52.49K | 1.01%134.24K | 85.70%26.87K |
Selling and administrative expenses | -72.40%10.27K | 1.27%27.93K | 11.69%32.24K | 119.12%161.27K | 314.24%67.63K | 89.85%37.19K | 40.02%27.58K | 60.49%28.87K | -44.62%73.6K | 12.82%16.33K |
-General and administrative expense | -72.40%10.27K | 1.27%27.93K | 11.69%32.24K | 119.12%161.27K | 314.24%67.63K | 89.85%37.19K | 40.02%27.58K | 60.49%28.87K | -44.62%73.6K | 12.82%16.33K |
Research and development costs | 46.01%21.42K | -29.03%12.13K | -0.21%22.92K | 125.56%78.47K | 125.24%23.75K | 41.77%14.67K | 55.73%17.09K | 684.59%22.97K | --34.79K | --10.55K |
Other operating expenses | ---- | -74.25%16.72K | -74.54%167 | 355.86%117.86K | --52.28K | ---- | 329.20%64.93K | --656 | --25.85K | --0 |
Operating profit | 38.91%-31.68K | 48.20%-56.77K | -5.41%-55.32K | -166.38%-357.6K | -434.61%-143.66K | -27.54%-51.86K | -139.30%-109.59K | -150.99%-52.49K | -1.01%-134.24K | -85.70%-26.87K |
Net non-operating interest income (expenses) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 188 | 0 |
Non-operating interest income | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --188 | --0 |
Other net income (expenses) | 6K | |||||||||
Other non-operating income (expenses) | ---- | ---- | ---- | --6K | ---- | ---- | ---- | ---- | ---- | ---- |
Income before tax | 38.91%-31.68K | 48.20%-56.77K | -5.41%-55.32K | -162.28%-351.6K | -412.28%-137.66K | -27.69%-51.86K | -139.82%-109.59K | -151.49%-52.49K | -0.87%-134.06K | -85.70%-26.87K |
Income tax | ||||||||||
Earnings from equity interest net of tax | ||||||||||
Net income | 38.91%-31.68K | 48.20%-56.77K | -5.41%-55.32K | -162.28%-351.6K | -412.28%-137.66K | -27.69%-51.86K | -139.82%-109.59K | -151.49%-52.49K | -0.87%-134.06K | -85.70%-26.87K |
Net income continuous operations | 38.91%-31.68K | 48.20%-56.77K | -5.41%-55.32K | -162.28%-351.6K | -412.28%-137.66K | -27.69%-51.86K | -139.82%-109.59K | -151.49%-52.49K | -0.87%-134.06K | -85.70%-26.87K |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 38.91%-31.69K | 48.20%-56.77K | -5.41%-55.32K | -162.28%-351.6K | -412.28%-137.66K | -27.69%-51.86K | -139.82%-109.59K | -151.49%-52.49K | -0.87%-134.06K | -85.70%-26.87K |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 38.91%-31.69K | 48.20%-56.77K | -5.41%-55.32K | -162.28%-351.6K | -412.28%-137.66K | -27.69%-51.86K | -139.82%-109.59K | -151.49%-52.49K | -0.87%-134.06K | -85.70%-26.87K |
Diluted earnings per share | 28.57%-0.0006 | 51.69%-0.0011 | 1.62%-0.001 | -267.51%-0.01 | -1,037.90%-0.0061 | -1.85%-0.0008 | -139.91%-0.0022 | -134.98%-0.001 | 7.70%-0.0027 | -66.04%-0.0005 |
Basic earnings per share | 28.57%-0.0006 | 51.69%-0.0011 | 1.62%-0.001 | -267.51%-0.01 | -1,029.42%-0.0061 | -1.85%-0.0008 | -139.91%-0.0022 | -134.98%-0.001 | 7.70%-0.0027 | -67.29%-0.0005 |
Dividend per share | ||||||||||
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.